If. Petersson et al., BONE-SCAN AND SERUM MARKERS OF BONE AND CARTILAGE IN PATIENTS WITH KNEE PAIN AND OSTEOARTHRITIS, Osteoarthritis and cartilage, 6(1), 1998, pp. 33-39
Objective: To study the relations between knee joint abnormalities, re
flected by bone scintigraphy and serum concentrations of cartilage oli
gomeric matrix protein (COMP) and bone sialoprotein (BSP). Design: In
a group of 38 individuals aged 37-54 years with chronic knee pain for
more than four years, both knees were investigated with bone scan. The
bone scans were graded for the extent of abnormalities. Radiographs o
f both knees were graded for tibiofemoral and patellofemoral osteoarth
ritis (OA). Serum levels of COMP and BSP were measured by immunoassays
. Results: Bone scan abnormalities were detected in 26/38 individuals
and radiographic OA in 23/38 individuals. The serum concentrations of
COMP and BSP were significantly higher in the individuals with bone sc
an abnormalities (P = 0.02 and P = 0.004, respectively). In addition,
the serum levels of COMP correlated positively with the extent of bone
scan abnormalities (N = 38), r = 0.56, P = 0.002. Serum BSP did not c
orrelate to the extent of scan abnormalities. Conclusions: In individu
als with knee pain, serum levels of COMP and BSP differ between those
with or without bone scan abnormalities in the knee joints. This sugge
sts that measurements of the serum levels of these markers have potent
ial as means for evaluation of tissue changes in individuals with long
standing knee pain in relation to early stages of OA.